[go: up one dir, main page]

Nie et al., 1999 - Google Patents

Nuclear respiratory factor‐2 subunit protein: Correlation with cytochrome oxydase and regulation by functional activity in the monkey primary visual cortex

Nie et al., 1999

Document ID
15111082998377541171
Author
Nie F
Wong‐Riley M
Publication year
Publication venue
Journal of Comparative Neurology

External Links

Snippet

Previous studies have shown that a transcription factor of the Ets family, nuclear respiratory factor 2 (NRF‐2), can activate in vitro the gene expression of cytochrome oxidase (CO), a mitochondrial enzyme of oxidative metabolism. The goals of our present study were to …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Similar Documents

Publication Publication Date Title
Lewis et al. Four isoforms of tyrosine hydroxylase are expressed in human brain
Yamashita et al. Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth
Chen et al. A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor
Tang Inhibitors of neuronal regeneration: mediators and signaling mechanisms
Wigge et al. Amphiphysin heterodimers: potential role in clathrin-mediated endocytosis
Zhou et al. Distribution and localization of pro‐brain‐derived neurotrophic factor‐like immunoreactivity in the peripheral and central nervous system of the adult rat
Koide et al. Antisperm antibodies associated with infertility: properties and encoding genes of target antigens
Camoratto et al. CEP‐751 inhibits trk receptor tyrosine kinase activity in vitro and exhibits anti‐tumor activity
Gil et al. c-Fos activated phospholipid synthesis is required for neurite elongation in differentiating PC12 cells
EP1049715A2 (en) Rho family antagonists and their use to block inhibition of neurite outgrowth
US6071709A (en) Nerve growth factor/receptor complex
WO2006108023A2 (en) Methods and compositions for modulating necdin function
Nie et al. Nuclear respiratory factor‐2 subunit protein: Correlation with cytochrome oxydase and regulation by functional activity in the monkey primary visual cortex
AU2014329606B2 (en) Methods for the identification, assessment, prevention, and treatment of neurological disorders and diseases using Fndc5
Lewis et al. Expression and distribution of two isoforms of tyrosine hydroxylase in macaque monkey brain
US20170100313A1 (en) Methods of inhibiting, protecting against, or treating uvr-induced skin damage
WO2005098433A2 (en) Diagnostic assays for alzheimer’s disease
Mendelzon et al. Phosphorylation of myogenin in chick myotubes: regulation by electrical activity and by protein kinase C. Implications for acetylcholine receptor gene expression
Lucas et al. Regulation of synthesis of p34cdc2 and its homologues and their relationship to p110Rb phosphorylation during cell cycle progression of normal human T cells
Qu et al. The synapse-associated protein rapsyn regulates tyrosine phosphorylation of proteins colocalized at nicotinic acetylcholine receptor clusters
Nie et al. Mitochondrial‐and nuclear‐encoded subunits of cytochrome oxidase in neurons: Differences in compartmental distribution, correlation with enzyme activity, and regulation by neuronal activity
Morishita et al. High expression of the γ5 isoform of G protein in neuroepithelial cells and its replacement of the γ2 isoform during neuronal differentiation in the rat brain
US7364870B2 (en) MK2 interacting proteins
Wishingrad et al. Ciliary neurotrophic factor stimulates the phosphorylation of two forms of STAT3 in chick ciliary ganglion neurons
Pincus et al. Pathways for activation of the ras-oncogene-encoded p21 protein